CellsBin

CellsBin's ultra-sensitive photonic-AI platform detects and isolates cells as rare as 1 in 10M, enabling single-cell characterization. Initial applications include non-invasive multiple myeloma diagnosis, risk stratification, and post-infusion monitoring of cell therapy.